FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057003766> ?p ?o ?g. }

• W2057003766 endingPage "548" @default.
• W2057003766 startingPage "537" @default.
• W2057003766 abstract "The newer purine nucleoside analogues (PNA), fludarabine (FAMP) and cladribine (2-chlorodeoxyadenosine, 2-CdA) have been synthesized recently and introduced into the treatment of chronic lymphocytic leukemia (CLL). The results of large phase II studies indicate that FAMP and 2-CdA are similarly active in CLL. Unfortunately, no prospective randomized study comparing the results of the treatment of CLL patients with FAMP and 2-CdA has been published so far. Significantly higher overall response (OR) and complete remission (CR) in patients treated initially with PNA than with chlorambucil or cyclophosphamide based combination regimens has been recently confirmed in five prospective multicentre randomized trials. These studies have also shown longer response duration in patients treated with PNA than with conventional chemotherapy. Overall survival progression free and events free survival were similar in patients treated with PNA and with chlorambucil or other alkylating agent based regimens. However, the majority of randomized trials were designed as cross over studies and most patients, treated with conventional chemotherapy were given PNA when refractory or in early relapse, which may influence the survival time. The results of a randomized study have shown a higher incidence of neutropenia and infections in patients treated with PNA than with chlorambucil. However. the frequency of autoimmune hemolytic anemia, pure red cell aplasia, secondary neoplasms and Richter's syndrome seems to be similar in patients treated with PNA and standard alkylating agents based chemotherapy. In conclusion, alkylating agents still have an important place in the routine management of the majority of CLL patients. They are in general safe, given on an out patients basis and significantly cheaper than PNA. PNA should be routinely used as second line treatment, and possibly as first line therapy in younger patients, who are candidates for potentially curative treatment such as stem cell transplantation and/or monoclonal antibodies." @default.
• W2057003766 created "2016-06-24" @default.
• W2057003766 creator A5087571749 @default.
• W2057003766 date "2002-01-01" @default.
• W2057003766 modified "2023-09-27" @default.
• W2057003766 title "The Role of Nucleoside Analogues in the Treatment of Chronic Lymphocytic Leukemia-Lessons Learned from Prospective Randomized Trials" @default.
• W2057003766 cites W129142841 @default.
• W2057003766 cites W1494274243 @default.
• W2057003766 cites W1499296962 @default.
• W2057003766 cites W159981870 @default.
• W2057003766 cites W1710792668 @default.
• W2057003766 cites W1854920159 @default.
• W2057003766 cites W1894269341 @default.
• W2057003766 cites W1906996655 @default.
• W2057003766 cites W1910475489 @default.
• W2057003766 cites W1968102342 @default.
• W2057003766 cites W1973279572 @default.
• W2057003766 cites W1977215846 @default.
• W2057003766 cites W1985065592 @default.
• W2057003766 cites W1988051901 @default.
• W2057003766 cites W1995570857 @default.
• W2057003766 cites W1997138132 @default.
• W2057003766 cites W1999292710 @default.
• W2057003766 cites W2004545336 @default.
• W2057003766 cites W2011382312 @default.
• W2057003766 cites W2015120596 @default.
• W2057003766 cites W2018847258 @default.
• W2057003766 cites W2026182828 @default.
• W2057003766 cites W2026901410 @default.
• W2057003766 cites W2028977711 @default.
• W2057003766 cites W2035858908 @default.
• W2057003766 cites W2038552887 @default.
• W2057003766 cites W2043165582 @default.
• W2057003766 cites W2045280629 @default.
• W2057003766 cites W2051278820 @default.
• W2057003766 cites W2055127867 @default.
• W2057003766 cites W2070193300 @default.
• W2057003766 cites W2072514745 @default.
• W2057003766 cites W2072539551 @default.
• W2057003766 cites W2091637935 @default.
• W2057003766 cites W2109876551 @default.
• W2057003766 cites W2111286556 @default.
• W2057003766 cites W2116058503 @default.
• W2057003766 cites W2116248495 @default.
• W2057003766 cites W2117848876 @default.
• W2057003766 cites W2132397975 @default.
• W2057003766 cites W2165963183 @default.
• W2057003766 cites W2166014786 @default.
• W2057003766 cites W2178644389 @default.
• W2057003766 cites W2221772045 @default.
• W2057003766 cites W2229733741 @default.
• W2057003766 cites W2255194647 @default.
• W2057003766 cites W2261126455 @default.
• W2057003766 cites W2317888977 @default.
• W2057003766 cites W2323490326 @default.
• W2057003766 cites W2325170605 @default.
• W2057003766 cites W2326175431 @default.
• W2057003766 cites W2337089158 @default.
• W2057003766 cites W2414892177 @default.
• W2057003766 cites W2995362154 @default.
• W2057003766 cites W4233161682 @default.
• W2057003766 cites W4235838915 @default.
• W2057003766 cites W4237192281 @default.
• W2057003766 cites W61714529 @default.
• W2057003766 cites W78071506 @default.
• W2057003766 cites W96780237 @default.
• W2057003766 doi "https://doi.org/10.1080/10428190290012029" @default.
• W2057003766 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12002757" @default.
• W2057003766 hasPublicationYear "2002" @default.
• W2057003766 type Work @default.
• W2057003766 sameAs 2057003766 @default.
• W2057003766 citedByCount "24" @default.
• W2057003766 countsByYear W20570037662016 @default.
• W2057003766 crossrefType "journal-article" @default.
• W2057003766 hasAuthorship W2057003766A5087571749 @default.
• W2057003766 hasConcept C109246011 @default.
• W2057003766 hasConcept C126322002 @default.
• W2057003766 hasConcept C143998085 @default.
• W2057003766 hasConcept C168563851 @default.
• W2057003766 hasConcept C181199279 @default.
• W2057003766 hasConcept C185592680 @default.
• W2057003766 hasConcept C2775952470 @default.
• W2057003766 hasConcept C2776476023 @default.
• W2057003766 hasConcept C2776543447 @default.
• W2057003766 hasConcept C2776694085 @default.
• W2057003766 hasConcept C2776755627 @default.
• W2057003766 hasConcept C2777333352 @default.
• W2057003766 hasConcept C2777866208 @default.
• W2057003766 hasConcept C2777938653 @default.
• W2057003766 hasConcept C2778461978 @default.
• W2057003766 hasConcept C2779200787 @default.
• W2057003766 hasConcept C2779263901 @default.
• W2057003766 hasConcept C2779338263 @default.
• W2057003766 hasConcept C2780653079 @default.
• W2057003766 hasConcept C55493867 @default.
• W2057003766 hasConcept C71240020 @default.
• W2057003766 hasConcept C71924100 @default.
• W2057003766 hasConcept C90924648 @default.

• next